The lung stent market expansion will be augmented by the extensive R&D investments funded by the public and private organizations for the advent of the non-vascular stent and growing incidences of COPD globally. As per the ODPHP, currently, there are more than 25 million people in the U.S suffering from asthma, along with 14.8 million adults being affected by COPD.
A high preference for minimally invasive surgeries to treat respiratory diseases would spur lung stent market growth in the coming years. The increased number of respiratory disorders associated with lung cancer has influenced the high adoption of minimally invasive surgeries among patients in a view to eliminating pain and incision caused during conventional surgeries.
Get sample copy of this research report @ https://www.decresearch.com/request-sample/detail/4873
Growing presence of patients going through airway complications might boost the Latin America lung stent industry. Countries like Brazil dominated the regional market while maintaining a valuation of over USD 2 million in 2019. As per the National Center for Biotechnology Information (NCBI), chronic obstructive pulmonary disease (COPD) is considered to be the sixth-most prevalent disorder in the country.
Brazil has a serious problem of burning sugarcane leaves on a large scale, which leads to the contraction of COPD. Besides, growing imposition of various federal health programs and initiatives to ease the supply and regulation of medical devices such as lung stents might further enhance the local business horizon.
Lung stent market share from the adult patient segment is estimated to grow at 14.7% CAGR in the upcoming years. There escalating prevalence of COPD in a large pool of adult patients due to smoking habits. Unhealthy lifestyles and stress cause high adoption of smoking habits among the adult population. As per the National Center for Biotechnology Information (NCBI), the prevalence of COPD in working adults aged between 40 to 70 years is estimated at around 4%.
Prominent companies in the global lung stent industry include Stening SRL, Novatech SA, Micro-Tech (Nanjing) Co., Ltd., Merit Medical Systems, Inc., Boston Medical Products, Inc., EFER ENDOSCOPY, Cook Group, Hood laboratories, and Boston Scientific Corporation, among others.
Taking October 2020 for instance, Medtronic plc, a leading medical technology company, revealed that it has bagged approval from the U.S. Food and Drug Administration (FDA) for its Abre™ venous self-expanding stent system.
Request for a Customization of this research report @ https://www.decresearch.com/roc/4873
Partial Chapter of the Table of Content
Chapter 4 Lung Stent Market, By Product
4.1 Key segment trends
4.2 Tracheal stents
4.2.1 Market size, by region, 2015– 2026 (USD Million)
4.3 Bronchial stents
4.3.1 Market size, by region, 2015 – 2026 (USD Million)
4.4 Laryngeal stents
4.4.1 Market size, by region, 2015 – 2026 (USD Million)
Chapter 5 Lung Stent Market, By Device Type
5.1 Key segment trends
5.2.1 Market size, by region, 2015 – 2026 (USD Million)
5.3.1 Market size, by region, 2015 – 2026 (USD Million)
Chapter 6 Lung Stent Market, By Material
6.1 Key segment trends
6.2.1 Market size, by region, 2015– 2026 (USD Million)
220.127.116.11.1 Market size, by region, 2015-2026 (USD Million)
18.104.22.168.1 Market size, by region, 2015-2026 (USD Million)
6.3.1 Market size, by region, 2015 – 2026 (USD Million)
6.4.1 Market size, by region, 2015 – 2026 (USD Million)
Chapter 7 Lung Stent Market, By Patient
7.1 Key segment trends
7.2.1 Market size, by region, 2015 – 2026 (USD Million)
7.3.1 Market size, by region, 2015 – 2026 (USD Million)
Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/lung-stent-market